BLB(SZ:002286) Zheng Quan Zhi Xing·2025-06-25 20:16Core Viewpoint - The report details the equity change of Baolingbao Biological Co., Ltd., indicating that Ningbo Baopu Futong Asset Management Center (Limited Partnership) has reduced its shareholding to below 10% through a centralized bidding transaction [1][2]. Group 1: Equity Change Details - The equity change was executed due to the information disclosure obligor's funding needs, resulting in a reduction of shares held from 38,139,244 shares (10.03354% of total shares) to 38,011,644 shares (9.99998%) [4][10]. - The reduction involved selling 127,600 shares at an average price of 10.86 RMB per share, accounting for a decrease of 0.03357% in the total shareholding [5][10]. - The total share capital of the company is reported to be 380,117,380 shares [8]. Group 2: Future Plans and Compliance - The information disclosure obligor has indicated potential plans to continue reducing its shareholding within the next 12 months, adhering to relevant laws and regulations [5][10]. - No other significant changes in shareholding structure or rights restrictions were reported, ensuring that the equity change does not affect the company's controlling shareholder or actual controller [8].